Vontobel Holding
NTLA icon

Vontobel Holding’s Intellia Therapeutics NTLA Stock Holding History

Vontobel Holding’s Portfolio NTLA Stock Details NTLA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$193K Buy
+15,048
New +$192K ﹤0.01% 1119
2022
Q2 		– Sell
-12,264
Closed -$885K – 1088
2022
Q1 		$885K Sell
12,264
-1,732
-12% -$147K 0.01% 654
2021
Q4 		$1.66M Buy
13,996
+10,296
+278% +$1.29M 0.01% 495
2021
Q3 		$496K Buy
+3,700
New +$560K ﹤0.01% 796

Other funds holding NTLA

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
RP
Regeneron Pharmaceuticals Tarrytown, New York $47.9M AUM 29.29% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Vontobel Holding's NTLA Position: Q1 2026 in Review

Vontobel Holding opened a new position in Intellia Therapeutics (NTLA) in Q1 2026: 15,048 shares worth $193K. The stake represents ﹤0.01% of the portfolio and ranks #1119 among its holdings. This is a return to the name: Vontobel Holding previously reported a position in NTLA as recently as Q1 2022.

Vontobel Holding first reported a position in NTLA in Q3 2021 and has held it in 4 quarters since. The position peaked at $1.66M in Q4 2021. 302 funds tracked by Wall St. Rank hold NTLA as of Q1 2026.

  • Vontobel Holding held 15,048 shares of Intellia Therapeutics worth $193K as of Q1 2026.
  • Intellia Therapeutics was a new Vontobel Holding position in Q1 2026.
  • Intellia Therapeutics made up ﹤0.01% of Vontobel Holding's portfolio in Q1 2026, its #1119 holding.
  • Vontobel Holding first reported a position in Intellia Therapeutics in Q3 2021 and has held it in 4 quarters since.
  • Vontobel Holding's Intellia Therapeutics position peaked at $1.66M in Q4 2021.
  • 302 funds tracked by Wall St. Rank held Intellia Therapeutics as of Q1 2026.

Based on Vontobel Holding's 13F filing for Q1 2026, filed 8 May 2026.